Effect of Semaglutide on MACE Risk Reduction Only Partly Explained by Known Risk Factors
WEDNESDAY, Sept. 30, 2026 -- The effects of semaglutide on major adverse cardiovascular events (MACE) is only partially due to known risk factors, according to a study published online Sept. 23 in the European Heart Journal.
Helen M. Colhoun, M.B...
Read more »